News

The company said that the cohort expansion comes after the initial stage of the trial confirmed that the maximum tolerated dose (MTD) of ME-344 in combination with topotecan

In addition to significantly strengthening the company’s balance sheet, Relmada’s CEO, Sergio Traversa, says the cash will help with its ambitious development strategy, "These funds enhance our flexibility

Bunionectomy surgery involves an incision in the top or side of the big toe joint and the removal or realignment of soft tissue and bone. Around 200-250 patients

Developed using modern recombinant technology, Flublok is the only flu vaccine that is 100% egg-free and highly purified. Flublok also contains three times more active ingredients than traditional

Specifically designed as a supplement for biological drug production, including biosimiliars, EX-CELL Glycosylation Adjust (Gal+) allows users to easily achieve desired N-linked glycosylation by increasing the galactose site

This is the first time in the current Ebola outbreak that EMA has given ‘rapid scientific advice’ using an accelerated procedure. EMA established this procedure to contribute to

The approval, issued in September 2014, allows Plandaí to grow cannabis in conjunction with the University, for medical research, which will be undertaken by students and scientists from

This financing was co-led by three new investors including AJU IB Investment Co., Ltd. and two undisclosed private investment groups. The round also includes full participation by all

XmAb5871 is a first-in-class monoclonal antibody containing Xencor’s proprietary immune inhibitor XmAb Fc domain that targets Fc?RIIb to inhibit B-cell function. XmAb5871 is currently in a Phase 1b/2a